Analysts have clear opinions on PGNY.

There are 1 analyst offering 12 month price targets for Progyny in the last 3 months. The average price target is $32.00 with a high forecast of $32.00 and a low forecast of $32.00. The average price target represents a 52.45% increase from the last price of $20.99.
Progyny, Inc. (PGNY) is followed by 1 analysts on the street.

null from rates it a .

Similarly, null of a with a target of .

The consensus on the street is null.

What does Progyny, Inc.(PGNY) do ?
Progyny, Inc. is a medical device company, which engages in the field of reproductive medicine, translating scientific discoveries related to early embryo development into clinical tools. Its services include egg freezing, IVF treatment, surrogacy, podcast, adoption, and Eeva Test. The company was founded on April 03, 2008 and is headquartered in New York, NY.

Progyny, Inc. (PGNY) Insider Trades

Multiple company employees have indulged in significant insider trading. Progyny, Inc. disclosed the following in a document filed with the US Securities and Exchange Commission (SEC):

Dir, Seidenberg Beth C : P – Purchase(+$999,999) of PGNY in the trading session of 2019-10-29.

EVP, GC Bealer Jennifer : S – Sale+OE(-$449,219) of PGNY in the trading session of 2019-10-29.

Dir Payson Norman : S – Sale+OE(-$6,953,107) of Progyny, Inc. in the trading session of 2019-10-29.